M

Magle Chemoswed Holding AB
STO:MAGLE

Watchlist Manager
Magle Chemoswed Holding AB
STO:MAGLE
Watchlist
Price: 32.6 SEK -4.12% Market Closed
Market Cap: 599.9m SEK
Have any thoughts about
Magle Chemoswed Holding AB?
Write Note

Magle Chemoswed Holding AB
Cash from Operating Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Magle Chemoswed Holding AB
Cash from Operating Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
M
Magle Chemoswed Holding AB
STO:MAGLE
Cash from Operating Activities
kr15.3m
CAGR 3-Years
N/A
CAGR 5-Years
7%
CAGR 10-Years
N/A
AddLife AB
STO:ALIF B
Cash from Operating Activities
kr773m
CAGR 3-Years
-7%
CAGR 5-Years
34%
CAGR 10-Years
N/A
BICO Group AB
STO:BICO
Cash from Operating Activities
kr178.4m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Biotage AB
STO:BIOT
Cash from Operating Activities
kr406m
CAGR 3-Years
6%
CAGR 5-Years
17%
CAGR 10-Years
19%
G
Genovis AB
STO:GENO
Cash from Operating Activities
kr37.3m
CAGR 3-Years
73%
CAGR 5-Years
60%
CAGR 10-Years
N/A
MedCap AB (publ)
STO:MCAP
Cash from Operating Activities
kr308.3m
CAGR 3-Years
41%
CAGR 5-Years
29%
CAGR 10-Years
28%
No Stocks Found

Magle Chemoswed Holding AB
Glance View

Market Cap
599.9m SEK
Industry
Life Sciences Tools & Services

Magle Chemoswed Holding AB engages in the provision of contract development and manufacturing services to the pharmaceutical and medical device industry. The company is headquartered in Malmo, Skane. The company went IPO on 2020-06-30. The firm's operations are mainly conducted through the subsidiaries Magle Chemoswed AB and Adroit Science AB. The business is focused on process development and manufacturing of Active Pharmaceutical Ingredients (API) as well as research, development and manufacturing of products in the areas of wound care and diagnostics with particular focus on products based on degradables starch microspheres. Magle Chemoswed also functions as a consultancy in material characterization and solid phase analysis with a main focus on pharmaceutical companies.

MAGLE Intrinsic Value
83.52 SEK
Undervaluation 61%
Intrinsic Value
Price
M

See Also

What is Magle Chemoswed Holding AB's Cash from Operating Activities?
Cash from Operating Activities
15.3m SEK

Based on the financial report for Dec 31, 2023, Magle Chemoswed Holding AB's Cash from Operating Activities amounts to 15.3m SEK.

What is Magle Chemoswed Holding AB's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
7%

Over the last year, the Cash from Operating Activities growth was 23%.

Back to Top